Alexium Confidentially Submits Registration Statement to the Securities and Exchange Commission for US Listing and Initial Public Offering of American Depositary Shares
(firmenpresse) - PERTH, AUSTRALIA and GREER, SC -- (Marketwired) -- 11/02/15 -- (ASX: AJX) (OTCQX: AXXIY) confirms it has confidentially submitted a draft F1 registration statement to the Securities and Exchange Commission (SEC) to conduct an initial public offering in the United States of its American Depositary Shares in conjunction with the planned listing on the NYSE MKT. The number of American Depositary Shares to be sold and the price range for the proposed offering has not yet been determined. The offering is expected to commence after the SEC completes its review process of its draft registration statement and after the Company sets the number of American Depositary Shares, price range and timetable according to market conditions.
This announcement is being made pursuant to and in accordance with Rule 135 under the Securities Act of 1933. As required by Rule 135, this press release does not constitute an offer to sell, or the solicitation of an offer to buy, securities, and shall not constitute an offer, solicitation, or sale in any jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of that jurisdiction.
ABN: 91 064 820 408
ASX: AJX
Alexium International Group Limited (ASX: AJX) (OTCQX: AXXIY) holds proprietary patent applications for a process developed initially by the U.S. Department of Defense, which allows for the surface modification and attachment of nano-particles or multiple chemical functional groups to surfaces or substrates to provide functions such as fire retardancy, water proofing, oil proofing, and anti-microbial treatments. Applications under development include but are not limited to textiles, paints, and packaging, glass and building materials. Alexium''s fire retardant chemical treatment are currently marketed for different fabric markets under the Alexiflam™, Ascalon™, Nycolon™, Nuvalon™, and Polytron™, Omnitron™ and Bactron™ trademarks.
Nick Clark
Chief Executive Officer
U.S.: +1 864.991.6687
Bradi Dobson
Marketing Specialist
8 Distribution Court
Greer, SC 29650
T: +1 864.416.1060
F: +1 864.752.6465
148 Milestone Way
Greenville, SC 29615
T: +1 864.603.1165
F: +1 864.752.6465
Matt Wright
Investor Relations
AUS: +61 451.896.420
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 02.11.2015 - 14:51 Uhr
Sprache: Deutsch
News-ID 1396192
Anzahl Zeichen: 4711
contact information:
Contact person:
Town:
PERTH, AUSTRALIA and GREER, SC
Phone:
Kategorie:
Aircraft
Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 284 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Alexium Confidentially Submits Registration Statement to the Securities and Exchange Commission for US Listing and Initial Public Offering of American Depositary Shares
"
steht unter der journalistisch-redaktionellen Verantwortung von
Alexium International Group (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
